DOA
RDY icon

D'Orazio & Associates’s Dr. Reddy's Laboratories RDY Stock Holding History

D'Orazio & Associates’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,550
Closed -$20K – 564
2021
Q3 		$20K Buy
+1,550
New +$20.7K ﹤0.01% 401

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

D'Orazio & Associates's RDY Position: Q4 2021 in Review

D'Orazio & Associates sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 1,550 shares — an estimated $20K sold.

D'Orazio & Associates first reported a position in RDY in Q3 2021 and held it in 1 quarter. The position peaked at $20K in Q3 2021. 147 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

  • D'Orazio & Associates reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
  • D'Orazio & Associates sold 1,550 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $20K.
  • D'Orazio & Associates first reported a position in Dr. Reddy's Laboratories in Q3 2021 and held it in 1 quarter.
  • D'Orazio & Associates's Dr. Reddy's Laboratories position peaked at $20K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.